Sigachi Industries Ltd
SIGC.IN
$0.81
Closing
▼-1.39%
1D
▲31.32%
YTD
Market cap
$266.04M
52 week high
$1.15
52 week low
$0.28
Volume
969,647
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$266.04M
Analysts' Rating
-
Price Target (Mean)
Unable to collect data for some field(s).
Total Analysts
0
P/E
45.92
Operating Margin
19.05%
Beta
Revenue Growth (Annual)
12.00%
52 week high
$1.15
52 week low
$0.28
Div. Yield
0.30%
EPS Annual Growth
0.00
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Sigachi Industries Limited is an India-based company that manufactures primarily microcrystalline cellulose (MCC). The Company is engaged in manufacturing cellulose-based excipients for finished dosages in the pharmaceutical industry. The Company’s products include EXCiPACT GMP, SGMP, HACCP and EDQM CEP. The Company’s pre-formulated excipients include BARETab PH, BARETab ODT and BARETab Nutra. It produces MCC in various grades ranging from 15 to 250 microns for the domestic and export markets under the HiCel and AceCel brands. The Company offers Anti-ulcers (Gastrointestinal) Products and their Intermediates. It operates over three manufacturing units situated in Hyderabad, Jhagadia and Dahej. The Company serves pharmaceutical, food and nutraceuticals, cosmetic and chemical industries. Its international business spreads across 50 countries, including Asia, Australia, American Continent, Europe and the Middle East.
